文献速递药疹与重症皮肤不良反应

英国Stevens-Johnson综合征与中毒性表皮坏死松解症的流行病学研究

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK.
PubMed 文献 · J Invest Dermatol · 2017-02-12

该研究基于英国临床实践研究数据链开展大型观察性研究,纳入551例经核实的SJS/TEN患者,计算1995至2013年发病率为5.76例/百万人年,发病率在1-10岁和80岁及以上患者中最高。病例对照分析显示黑人和亚洲患者风险为白人的2倍,癫痫或痛风患者仅在接受抗癫痫药或别嘌醇新药治疗时风险显著增加。

要点

  • SJS/TEN年发病率为5.76例/百万人年,1-10岁和≥80岁人群发病率最高
  • 黑人和亚洲患者SJS/TEN风险约为白人的2倍
  • 癫痫或痛风患者仅近期新用抗癫痫药或别嘌醇时风险显著增加

核心结论

  • 英国SJS/TEN年发病率为5.76例/百万人年,研究期间保持稳定,年龄和种族影响风险。
  • 癫痫或痛风患者仅近期新用抗癫痫药或别嘌醇时SJS/TEN风险显著增加。
  • 抑郁、红斑狼疮、近期肺炎、慢性肾病和活动性癌症与SJS/TEN存在统计学显著关联,但需随访药物混杂。

研究设计与样本

  • 基于英国临床实践研究数据链的大型观察性研究,纳入551例经核实的SJS/TEN患者。
  • 采用1:4匹配的病例对照分析。

主要发现

  • 1995至2013年SJS/TEN发病率为5.76例/百万人年,研究期间一致,1-10岁和80岁及以上患者发病率最高。
  • 黑人和亚洲患者较白人患者SJS/TEN风险为2倍。
  • 癫痫患者仅近期新用抗癫痫药时SJS/TEN比值比显著增加,痛风患者仅近期新用别嘌醇时比值比显著增加。
  • SJS/TEN与既存抑郁、红斑狼疮、近期肺炎、慢性肾病和活动性癌症存在统计学显著关联。

关键数值与推荐

  • SJS/TEN发病率:5.76例/百万人年(1995-2013年)。
  • 黑人和亚洲患者较白人患者风险比为2倍。
  • 癫痫和痛风患者仅近期新用抗癫痫药或别嘌醇时SJS/TEN比值比显著增加。

临床怎么用

  • 临床应关注1-10岁和80岁及以上人群的SJS/TEN风险。
  • 对黑人和亚洲患者使用可疑药物时需提高警惕。
  • 癫痫或痛风患者近期新用抗癫痫药或别嘌醇时应监测SJS/TEN迹象。

局限性

  • 药物使用混杂需进一步随访研究。
  • 研究人群主要为欧洲白人,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening mucocutaneous diseases. SJS/TEN mostly manifest as a reaction to new drug use, but little is known about their incidence and epidemiology. We conducted a large observational study on the epidemiology of SJS/TEN using data from the UK-based Clinical Practice Research Datalink. Among 551 validated SJS/TEN patients, we calculated an incidence rate of 5.76 SJS/TEN cases per million person-years between 1995 and 2013, which was consistent throughout the study period and was highest in patients aged 1-10 years and 80 years or older. Within a 1:4 matched case-control analysis, black and Asian patients were at a 2-fold risk of SJS/TEN when compared with white patients. Among patients with epilepsy and gout, odds ratios for SJS/TEN were significantly increased only in the presence of recent new drug treatment with antiepileptics or allopurinol, respectively. We observed statistically significant associations between SJS/TEN and pre-existing depression, lupus erythematosus, recent pneumonia, chronic kidney disease, and active cancer, but confounding by drug use needs to be followed up. This large and longitudinal observational study on the epidemiology of SJS/TEN contributes to the understanding of this still underinvestigated severe skin disease in a European and largely white study population.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Frey N, Jossi J, Bodmer M, et al. The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK. J Invest Dermatol. 2017. PMID: 28202399. doi:10.1016/j.jid.2017.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。